Benny whilst this thread has nothing to do with Meb - a little advice - dig deep into its history and the buy out of it. It's algorithms have been ignored for a money first patient later mentality. Whilst medical start ups can bee harpooned by CEOs and BODs more focussed on medicine than business Meb is the opposite. I have stuck with GMV because I feel Yacov understands both sides of the equation. DYOR but I bailed on Meb for the first reason
- Forums
- ASX - By Stock
- GMV
- Ann: CE, FDA and CFDA Approval - Guangzhou Production Facility
Ann: CE, FDA and CFDA Approval - Guangzhou Production Facility, page-533
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online